首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >The effects of reported Ca2+ sensitisers on the rates of Ca2+ release from cardiac troponin C and the troponin-tropomyosin complex.
【2h】

The effects of reported Ca2+ sensitisers on the rates of Ca2+ release from cardiac troponin C and the troponin-tropomyosin complex.

机译:报道的Ca2 +增敏剂对心肌肌钙蛋白C和肌钙蛋白-肌球蛋白复合物的Ca2 +释放速率的影响。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. The calcium sensitivity of force production of cardiac muscle fibres is altered by certain drugs. The sites of action of three such compounds (pimobendan, sulmazole, isomazole) within the myofibril have been investigated. Calmodulin antagonists, perhexilene and bepridil, which have been shown to alter the calcium dependence of myofibrillar ATPase activity and oxmetidine, an H2-receptor antagonist which binds to calmodulin, were also studied. 2. The rates of dissociation of calcium from both the regulatory and high affinity sites on bovine isolated cardiac troponin C (cTnC) were measured in a stopped-flow fluorimeter. The rates of dissociation were found to be 136.5 +/- 16 s-1 and 1.3 +/- 0.20 s-1 (mean +/- s.e.mean, n = 11 determinations; conditions: 100 mM KCl, 10 mM MOPS, 3 mM MgCl2, 0.1 mM dithriothreitol, pH 7.0, 15 degrees C). Sulmazole, isomazole and perhexiline (final concentration of 50 microM) had no effect on the rate of Ca2+ dissociation from the regulatory Ca2+ site, indicating that these compounds do not act on cTnC directly. 3. The rate of dissociation of Ca2+ from the regulatory site was slightly reduced (approximately 20%) by pimobendan (50 and 100 microM) and was somewhat increased by oxmetidine (28% at 100 microM). 4. Bepridil (25 microM) reduced the rate of dissociation by 50%, indicating a direct effect of bepridil on TnC. 5. Sulmazole, isomazole, perhexiline, pimobendan (50 microM) and bepridil (25 microM) were without effect on the rate of dissociation of Ca2+ from the high affinity Ca2+/Mg2+ sites. Oxmetidine caused 24% decrease in the rate of Ca2+ dissociation from these sites.(ABSTRACT TRUNCATED AT 250 WORDS)
机译:1.某些药物会改变心肌纤维产生力的钙敏感性。已经研究了肌原纤维中三种此类化合物(匹莫苯,舒马唑,异唑)的作用位点。还研究了钙调蛋白拮抗剂perhexilene和bepridil改变了肌原纤维ATPase活性对钙的依赖性,而奥美替丁是一种与钙调蛋白结合的H2受体拮抗剂。 2.在停流荧光计中测量了钙从牛离体心脏肌钙蛋白C(cTnC)的调节位点和高亲和力位点解离的速率。发现解离速率为136.5 +/- 16 s-1和1.3 +/- 0.20 s-1(平均+/- semean,n = 11次测定;条件:100 mM KCl,10 mM MOPS,3 mM MgCl2,0.1 mM二苏糖醇,pH 7.0,15摄氏度。 Sulmazole,isomazole和perhexiline(最终浓度为50 microM)对Ca2 +从调节性Ca2 +位点解离的速率没有影响,表明这些化合物并不直接作用于cTnC。 3.吡莫苯丹(50和100 microM)使Ca2 +从调节位点解离的速率略有降低(约20%),而奥美替丁(100 microM则为28%)有所提高。 4. Bepridil(25 microM)将解离速率降低了50%,表明bepridil对TnC有直接作用。 5. Sulmazole,isomazole,perhexiline,pimobendan(50 microM)和bepridil(25 microM)对Ca2 +从高亲和力Ca2 + / Mg2 +位点解离的速率没有影响。奥美替丁使这些部位的Ca2 +解离速率降低了24%。(摘要截断为250字)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号